AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$371M
This Quarter Return
-7.88%
1 Year Return
+16.18%
3 Year Return
+64.49%
5 Year Return
+102.68%
10 Year Return
–
AUM
$458M
AUM Growth
+$458M
(-14%)
Cap. Flow
-$38.1M
Cap. Flow
% of AUM
-8.32%
Top 10 Holdings %
Top 10 Hldgs %
19.44%
Holding
170
New
12
Increased
37
Reduced
105
Closed
16
Top Buys
| 1 |
Stevanato
STVN
|
$8.2M |
| 2 |
CCC Intelligent Solutions
CCCS
|
$6.68M |
| 3 |
Procore
PCOR
|
$4.24M |
| 4 |
Trex
TREX
|
$4.21M |
| 5 |
AvidXchange
AVDX
|
$4.19M |
Top Sells
| 1 |
FirstCash
FCFS
|
$8.01M |
| 2 |
GMS Inc
GMS
|
$7.17M |
| 3 |
Kirby Corp
KEX
|
$6.91M |
| 4 |
First American
FAF
|
$6.89M |
| 5 |
HRT
HireRight Holdings Corporation
HRT
|
$6.81M |
Sector Composition
| 1 | Industrials | 28.53% |
| 2 | Technology | 23.09% |
| 3 | Consumer Discretionary | 12.07% |
| 4 | Healthcare | 11.44% |
| 5 | Financials | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SLM Corp
SLM
$6.44B
| $2.27M | 0.5% |
109,198
-60,164
| -36% | -$1.25M |
|
77
MSC Industrial Direct
MSM
$5.03B
| $2.13M | 0.46% |
26,794
-32,065
| -54% | -$2.54M |
|
78
Helios Technologies
HLIO
$1.75B
| $2.04M | 0.44% |
42,636
-16,204
| -28% | -$774K |
|
79
Ingevity
NGVT
$2.11B
| $1.95M | 0.43% |
44,653
-31,108
| -41% | -$1.36M |
|
80
National Vision
EYE
$1.8B
| $1.92M | 0.42% |
146,450
+23,390
| +19% | +$306K |
|
81
Omnicell
OMCL
$1.51B
| $1.89M | 0.41% |
69,773
-38,181
| -35% | -$1.03M |
|
82
ADMA Biologics
ADMA
$4.03B
| $1.72M | 0.37% |
153,551
-30,915
| -17% | -$346K |
|
83
Halozyme
HALO
$8.75B
| $1.28M | 0.28% |
24,506
-2,573
| -10% | -$135K |
|
84
Vericel Corp
VCEL
$1.69B
| $1.04M | 0.23% |
22,611
-2,377
| -10% | -$109K |
|
85
Organogenesis Holdings
ORGO
$629M
| $1M | 0.22% |
358,454
-37,662
| -10% | -$105K |
|
86
Veracyte
VCYT
$2.41B
| $991K | 0.22% |
45,729
-4,805
| -10% | -$104K |
|
87
Dynavax Technologies
DVAX
$1.19B
| $901K | 0.2% |
80,250
-8,433
| -10% | -$94.7K |
|
88
MiMedx Group
MDXG
$1.05B
| $877K | 0.19% |
126,592
-13,301
| -10% | -$92.2K |
|
89
Voyager Therapeutics
VYGR
$204M
| $875K | 0.19% |
110,681
-11,630
| -10% | -$92K |
|
90
Alkermes
ALKS
$4.95B
| $851K | 0.19% |
35,298
-3,710
| -10% | -$89.4K |
|
91
Xencor
XNCR
$594M
| $812K | 0.18% |
42,871
-4,504
| -10% | -$85.3K |
|
92
Ironwood Pharmaceuticals
IRWD
$201M
| $773K | 0.17% |
118,514
-12,452
| -10% | -$81.2K |
|
93
Arcturus Therapeutics
ARCT
$467M
| $658K | 0.14% |
27,040
-2,841
| -10% | -$69.2K |
|
94
MannKind Corp
MNKD
$1.69B
| $652K | 0.14% |
+124,968
| New | +$652K |
|
95
Acadia Pharmaceuticals
ACAD
$4.34B
| $619K | 0.14% |
+38,074
| New | +$619K |
|
96
TG Therapeutics
TGTX
$5.03B
| $605K | 0.13% |
+34,030
| New | +$605K |
|
97
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $584K | 0.13% |
+31,258
| New | +$584K |
|
98
Catalyst Pharmaceutical
CPRX
$2.42B
| $578K | 0.13% |
+37,320
| New | +$578K |
|
99
Cactus
WHD
$2.77B
| $512K | 0.11% |
9,699
-1,054
| -10% | -$55.6K |
|
|
SBOW
100
DELISTED
SilverBow Resources, Inc.
SBOW
| $477K | 0.1% |
12,598
-1,370
| -10% | -$51.8K |
|